文献速递神经与头颈病理细胞病理与分子病理

甲状腺滤泡上皮细胞源性肿瘤的分子病理学更新

Molecular Pathology of Thyroid Follicular Epithelial Cell-Derived Neoplasia: An Update.
PubMed 文献 · Arch Pathol Lab Med · 2025-12-22

该综述回顾2011年关于甲状腺肿瘤分子特征的文章,比较甲状腺乳头状癌与滤泡性肿瘤的遗传学差异,并讨论此后诊断分类重组、分子检测平台多样化等进展,指出分子分析已融入甲状腺结节评估到管理的各环节。

要点

  • 甲状腺乳头状癌与滤泡性肿瘤的分子特征区别仍具临床相关性。
  • 分子改变可指导甲状腺结节诊断分类与治疗管理。
  • 诊断分类重组与分子检测平台多样化是2011年后的重要变化。

核心结论

  • 甲状腺乳头状癌与滤泡性肿瘤的分子特征区别及侵袭性癌相关改变仍是当前重要概念。
  • 2011年后的重要变化包括诊断分类重组、非肿瘤性病变中分子改变的可能性及分子检测平台多样化。
  • 甲状腺结节分子分析现已纳入从初始评估到明确分类及后续管理指导的各个环节。

研究设计与样本

  • 综述通过评估原始文献和综述文章,讨论原综述涉及的主题并衡量其发表后的进展。

主要发现

  • 甲状腺癌中可识别致病性分子改变的比例高达90%。
  • 甲状腺乳头状癌与滤泡性肿瘤的分子特征差异及侵袭性癌相关改变仍具相关性。

临床怎么用

  • 甲状腺结节分子分析可用于初始评估、明确分类及后续管理指导。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT.—: Thyroid gland neoplasia comprises the most common group of tumors arising within organs of the endocrine system. Pathogenic molecular changes can now be identified in up to 90% of thyroid carcinomas. These alterations not only shape our understanding of tumor biology and classification, but also increasingly guide therapeutic approaches to these diseases. OBJECTIVE.—: To revisit a frequently cited review article from 2011 that outlined fundamental differences between tumor types-primarily papillary thyroid carcinoma and follicular neoplasia-in terms of their underlying genetic profiles. The present review discusses the aspects of the preceding manuscript that have remained salient, as well as advances in thyroid molecular pathology that have transpired in the intervening years. DATA SOURCES.—: Primary literature and review articles were evaluated in order to consider topics addressed in the original review, and to gauge progress that has occurred since its publication. CONCLUSIONS.—: The distinction between the respective molecular signatures of papillary thyroid carcinoma and follicular neoplasia, and the specter of alterations associated with aggressive cancers, remain pertinent in the present era. Important changes since 2011 relate to the reorganization of diagnostic categories, the prospect of molecular alterations in (or their incompatibility with) nonneoplastic processes, and the variety of available molecular testing platforms. Molecular analysis of thyroid nodules now factors into every step along the gamut from initial assessment to definitive classification to subsequent guidance of management. Nikiforov's review established a conceptual framework around thyroid neoplasia that has evolved over time, but endures as the dominant paradigm regarding these tumors.

来源:Arch Pathol Lab Med,查看原文。版权归原作者所有。

引用

  1. Turk AT. Molecular Pathology of Thyroid Follicular Epithelial Cell-Derived Neoplasia: An Update. Arch Pathol Lab Med. 2025. PMID: 41429177. doi:10.5858/arpa.2025-0258-RA

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。